Your session is about to expire
← Back to Search
REACT for Chronic Kidney Disease in Diabetics
Study Summary
This trial is testing a new way to inject medication into the kidneys to see if it can help improve kidney function in people with diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My kidney function is low but I don't need dialysis.My kidney problems are due to diabetes.My kidney function is low but I don't need dialysis.Your average blood pressure is too high during the screening.Your HbA1c level is less than 10%.I have had a kidney transplant.I have been diagnosed with type 1 or type 2 diabetes and it is under control.I am between 30 and 80 years old.My hemoglobin is below 10 g/dL and treatments for anemia due to kidney disease haven't worked.
- Group 1: 2 REACT injections
- Group 2: 1 REACT Injection
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any vacancies available for the current clinical trial?
"Yes, according to clinicaltrials.gov this trial is actively seeking enrolment. It was first posted on the 27th of July 2021 and underwent a recent update on October 25 2022. The study requires 50 participants from 5 different sites for its completion."
Could you provide information on the potential risks of Renal Autologous Cell Therapy (REACT®) for patients?
"With its Phase 2 trial, Renal Autologous Cell Therapy (REACT®) has some evidence of safety- hence the score of 2. Unfortunately, there are currently no data sets attesting to its efficacy."
What is the cumulative enrollment for this trial?
"Correct. Per the clinicaltrials.gov page, this medical trial is in full swing and has been since it was first posted on July 27th 2021. The study needs to recruit 50 people from 5 clinics before its completion date of October 25th 2022."
How prevalent is this trial across the city's healthcare centers?
"There are 5 recruiting sites for this scientific study, including the Boise Kidney and Hypertension Institute - Frenova in Nampa, Paragon Health, PC d/b/a Nephrology Center-Frenova in Kalamazoo, and Kidney Associates of Colorado P.C.-Frenova in Denver; two additional locations also offer enrollment opportunities."
Is it possible for me to join this scientific research project?
"Applicants for this clinical trial must have type 2 diabetes mellitus, be between 30 and 80 years old, and the study is able to accept 50 individuals."
Does the age requirement for this trial extend below 30 years of age?
"According to the qualifying parameters, those eligible for this trial must be over 30 years of age and no older than 80."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger